25823942

Xia Y

2015

Epigenetic pattern changes in prenatal female Sprague-Dawley rats following exposure to androgen.

25823959

Guidi J

2015

Psychological aspects of hyperandrogenic states in late adolescent and young women.

25824095

Mani H

2015

Clinical characteristics of polycystic ovary syndrome: investigating differences in White and South Asian women.

25824582

Zhu L

2015

Confocal Microscopic Analysis of the Spindle and Chromosome Configurations of in vitro-Matured Oocytes from Different Types of Polycystic Ovary Syndrome Patients.

25825716

Wang F

2015

Alternative splicing of the androgen receptor in polycystic ovary syndrome.

25826962

Vital-Reyes VS

2014

[Insulin resistance frecuency in women's with polycystic ovary syndrome using hyperinsulinemic-euglycemic clamp].

25826979

Grzyb E

2014

[Epilepsy, antiepileptic drugs and disorders of reproductive functions of women].

25828622

Orio F

2015

Could the Mediterranean diet be effective in women with polycystic ovary syndrome? A proof of concept.

25832114

Cardoso RC

2015

Steroidogenic versus Metabolic Programming of Reproductive Neuroendocrine, Ovarian and Metabolic Dysfunctions.

25832152

Twigg SM

2015

The imperative to prevent diabetes complications: a broadening spectrum and an increasing burden despite improved outcomes.

25833060

Witchel SF

2015

The Diagnosis of Polycystic Ovary Syndrome during Adolescence.

25833092

Annag?r BB

2015

Psychiatric comorbidity in women with polycystic ovary syndrome.

25835506

de Melo AS

2015

Pathogenesis of polycystic ovary syndrome: multifactorial assessment from the foetal stage to menopause.

25835559

Moghetti P

2015

How to manage the reproductive issues of PCOS: a 2015 integrated endocrinological and gynecological consensus statement of the Italian Society of Endocrinology.

25837186

Park SY

2015

Triglyceride is a useful surrogate marker for insulin resistance in Korean women with polycystic ovary syndrome.

25837320

Taskin MI

2015

Circulating levels of obestatin and copeptin in obese and nonobese women with polycystic ovary syndrome.

25837360

Qiu L

2015

Association between two polymorphisms of follicle stimulating hormone receptor gene and susceptibility to polycystic ovary syndrome: a meta-analysis.

25840428

de Wilde MA

2015

Insulin action in women with polycystic ovary syndrome and its relation to gestational diabetes.

25840648

Rosenfield RL

2015

The Polycystic Ovary Morphology-Polycystic Ovary Syndrome Spectrum.

25841599

Gill SK

2015

Cardiovascular risk factors and disease in women.

25843520

Benito V

2015

Bariatric Surgery: Does It Play a Role in Fertility-Preserving Treatment Among Obese Young Women With Endometrial Cancer?

25850587

S?klar Z

2015

Diagnostic characteristics and metabolic risk factors of cases with polycystic ovary syndrome during adolescence.

25850593

Amr N

2015

The effect of chromium supplementation on polycystic ovary syndrome in adolescents.

25850594

Turan V

2015

Infertility and the presence of insulin resistance are associated with increased oxidative stress in young, non-obese Turkish women with polycystic ovary syndrome.

25854013

Jiang D

2015

[Infertility in polycystic ovary syndrome treated with acupuncture and clomiphene: a randomized controlled trial].

25856211

Polotsky AJ

2015

Impact of Male and Female Weight, Smoking, and Intercourse Frequency on Live Birth in Women With Polycystic Ovary Syndrome.

25857311

Sam S

2015

Metabolic dysfunction in obese Hispanic women with polycystic ovary syndrome.

25859492

Yanamandra NK

2015

Outcome of ovarian drilling in women with polycystic ovary syndrome.

25860656

Dong F

2015

Serum metabolomics study of polycystic ovary syndrome based on UPLC-QTOF-MS coupled with a pattern recognition approach.

25864247

Li W

2014

Association of sympathetic nervous system activity with polycystic ovarian syndrome.

25864278

Hacivelioglu S

2015

The effect of maternal polycystic ovary morphology on first-trimester maternal serum biochemical markers of aneuploidy and fetal nuchal translucency thickness.

25866568

Dumitrescu R

2015

The polycystic ovary syndrome: an update on metabolic and hormonal mechanisms.

25866577

Dumitrescu R

2015

Metformin-clinical pharmacology in PCOs.

25868059

Foroozanfard F

2015

Effects of zinc supplementation on markers of insulin resistance and lipid profiles in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial.

25869556

Bloem LM

2015

Advances in the analytical methodologies: Profiling steroids in familiar pathways-challenging dogmas.

25870722

Kalenda LM

2014

[Study of clinical, sonographic and nutritional aspects of polycystic ovary syndrome (PCOS) in Mbuji-Mayi, DR Congo].

25873949

Tan S

2015

Liver Injury Indicating Fatty Liver but Not Serologic NASH Marker Improves under Metformin Treatment in Polycystic Ovary Syndrome.

25874409

Khomami MB

2015

Of PCOS symptoms, hirsutism has the most significant impact on the quality of life of Iranian women.

25876344

Jin CL

2014

[Efficacy comparison between electroacupuncture and dyne-35 in treatment of polycystic ovary syndrome].

25878392

Sharmila V

2015

Oral contraceptive pills induced hemichorea in an adolescent female with polycystic ovarian disease.

25878664

Macut D

2015

Predictors of subclinical cardiovascular disease in women with polycystic ovary syndrome: interrelationship of dyslipidemia and arterial blood pressure.

25878993

Abazar E

2015

Effects of aerobic exercise on plasma lipoproteins in overweight and obese women with polycystic ovary syndrome.

25879001

Aghadavod E

2015

Evaluation of relationship between serum levels of anti-m?llerian hormone, androgen, and insulin resistant with retrieval oocytes in overweight patients with polycystic ovary syndrome.

25879641

Legro R

2015

Diagnosis and treatment of polycystic ovary syndrome (PCOS): an interview with Richard Legro.

25880215

Tar?n JJ

2015

Infertility etiologies are genetically and clinically linked with other diseases in single meta-diseases.

25880805

Kahal H

2015

The effects of treatment with liraglutide on atherothrombotic risk in obese young women with polycystic ovary syndrome and controls.

25881575

Chen J

2015

The correlation of aromatase activity and obesity in women with or without polycystic ovary syndrome.

25881987

Venturella R

2015

OvAge: a new methodology to quantify ovarian reserve combining clinical, biochemical and 3D-ultrasonographic parameters.

25884893

Niafar M

2015

Adiponectin as serum biomarker of insulin resistance in patients with polycystic ovarian syndrome.

25884894

Ozcan Dag Z

2015

Personality profile in patients with polycystic ovary syndrome.

25885106

Jensterle M

2015

A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome.

25887459

Salilew-Wondim D

2015

Polycystic ovarian syndrome is accompanied by repression of gene signatures associated with biosynthesis and metabolism of steroids, cholesterol and lipids.

25889494

Kai Y

2015

A possible role for AMP-activated protein kinase activated by metformin and AICAR in human granulosa cells.

25893270

Cianci A

2015

d-chiro-Inositol and alpha lipoic acid treatment of metabolic and menses disorders in women with PCOS.

25899185

Ainuddin JA

2015

Metformin for preventing gestational diabetes in women with polycystic ovarian syndrome.

25902044

Li L

2015

Genetic variation in the Mcp-1 gene promoter associated with the risk of polycystic ovary syndrome.

25902782

Moore SF

2015

Loss of the insulin receptor in murine megakaryocytes/platelets causes thrombocytosis and alterations in IGF signalling.

25904635

Saxena R

2015

Han Chinese polycystic ovary syndrome risk variants in women of European ancestry: relationship to FSH levels and glucose tolerance.

25904637

S?nchez F

2015

Human cumulus-enclosed germinal vesicle oocytes from early antral follicles reveal heterogeneous cellular and molecular features associated with in vitro maturation capacity.

25904961

Bagheri M

2015

Comparison of Biomedical Variables in PCOS Patients with Normal Iranian Women.

25905194

Legro RS

2000

Evaluation and Treatment of Polycystic Ovary Syndrome

25905297

Marques P

2000

Physiology of Gnrh and Gonadotropin Secretion

25909141

Ganovska A

2015

[Hyperandrogenism in multiple pregnancy].

25911850

Deepika ML

2014

Analysis of oxidative stress status through MN test and serum MDA levels in PCOS women.

25912571

Benk Silfeler D

2015

Demodex folliculorum in polycystic ovary syndrome patients.

25916434

Pecori Giraldi F

2015

PseudoCushing: why a clinical challenge?

25918586

Moini A

2015

Comparison of 25-hydroxyvitamin D and Calcium Levels between Polycystic Ovarian Syndrome and Normal Women.

25918587

Zahiri Sorouri Z

2015

Comparison between Unilateral and Bilateral Ovarian Drilling in Clomiphene Citrate Resistance Polycystic Ovary Syndrome Patients: A Randomized Clinical Trial of Efficacy.

25918921

van Zuuren EJ

2015

Interventions for hirsutism (excluding laser and photoepilation therapy alone).

25919188

Padmanabhan V

2015

Developmental Programming: Prenatal and Postnatal Androgen Antagonist and Insulin Sensitizer Interventions Prevent Advancement of Puberty and Improve LH Surge Dynamics in Prenatal Testosterone-Treated Sheep.

25919204

Sandeep PM

2015

Anti-Androgenic Activity of Nardostachys jatamansi DC and Tribulus terrestris L. and Their Beneficial Effects on Polycystic Ovary Syndrome-Induced Rat Models.

25920315

Lewandowski KC

2015

Spuriously high androstendione concentrations due to assay interference as a cause of diagnostic conundrum in women with oligomenorrhoea.

25920524

Ashrafi M

2015

Predictive factors of early moderate/severe ovarian hyperstimulation syndrome in non-polycystic ovarian syndrome patients: a statistical model.

25924437

Gong J

2015

[Study on the oxidative stress in the ovaries of a rat model of polycystic ovary].

25924640

Reismullerova L

2015

Polycystic ovary syndrome - a risk factor of pre-eclampsia after in vitro fertilisation.

25925351

Sundvall L

2015

Unaltered timing of embryo development in women with polycystic ovarian syndrome (PCOS): a time-lapse study.

25926334

Lambert EA

2015

Sympathetic activation and endothelial dysfunction in polycystic ovary syndrome are not explained by either obesity or insulin resistance.

25927028

Bagheri M

2015

An Association Study between INSR/NsiI (rs2059806) and INSR/PmlI (rs1799817) SNPs in Women with Polycystic Ovary Syndrome from West Azerbaijan Province, Iran.

25929256

Vitagliano A

2016

Statins as Targeted Magical Pills for the Conservative Treatment of Endometriosis: May Potential Adverse Effects on Female Fertility Represent the Dark Side of the Same Coin? A Systematic Review of Literature.

25929428

Hedstr?m H

2015

Women with polycystic ovary syndrome have elevated serum concentrations of and altered GABA(A) receptor sensitivity to allopregnanolone.

25931457

Hua J

2015

Follicle Online: an integrated database of follicle assembly, development and ovulation.

25934594

Fruzzetti F

2015

Ovarian volume in normal and hyperandrogenic adolescent women.

25935176

Saleh BO

2015

The role of anti-Mullerian hormone and inhibin B in the assessment of metformin therapy in women with polycystic ovarian syndrome.

25935491

Juan CC

2015

Endocannabinoid system activation may be associated with insulin resistance in women with polycystic ovary syndrome.

25935493

Bellver J

2015

Day-3 embryo metabolomics in the spent culture media is altered in obese women undergoing in vitro fertilization.

25941189

Zheng Y

2015

How does acupuncture affect insulin sensitivity in women with polycystic ovary syndrome and insulin resistance? Study protocol of a prospective pilot study.

25941819

Li L

2015

Molecular genetics of polycystic ovary syndrome: an update.

25949777

Shoaei T

2015

Effects of Probiotic Supplementation on Pancreatic ?-cell Function and C-reactive Protein in Women with Polycystic Ovary Syndrome: A Randomized Double-blind Placebo-controlled Clinical Trial.

25951635

Li J

2015

[Effect of electro-acupuncture on the spindle and oocytes quality in patients with PCOS].

25951648

Wu LL

2015

[Advance in acupuncture treatment of polycystic ovarian syndrome].

25953664

Hatanaka Y

2015

Abnormal instability, excess density, and aberrant morphology of dendritic spines in prenatally testosterone-exposed mice.

25955687

Wang K

2015

Contrasting Sleeve Gastrectomy with Lifestyle Modification Therapy in the Treatment of Polycystic Ovary Syndrome.

25955958

Rezvanfar MA

2016

Dual targeting of TNF-? and free radical toxic stress as a promising strategy to manage experimental polycystic ovary.

25956362

Yu YY

2015

Genome-wide screen of ovary-specific DNA methylation in polycystic ovary syndrome.

25956367

Dadachanji R

2015

PON1 polymorphisms are associated with polycystic ovary syndrome susceptibility, related traits, and PON1 activity in Indian women with the syndrome.

25956684

Diamanti-Kandarakis E

2016

Advanced glycation end-products and insulin signaling in granulosa cells.

25957668

Moran LJ

2015

Steroidal contraceptive use is associated with lower bone mineral density in polycystic ovary syndrome.

25957872

Lenouvel D

2015

Late Reactivation of Cherubism in a Patient With New-Onset Polycystic Ovary Syndrome.

25963796

Maliqueo M

2015

Circulating gonadotropins and ovarian adiponectin system are modulated by acupuncture independently of sex steroid or ?-adrenergic action in a female hyperandrogenic rat model of polycystic ovary syndrome.

25965123

Abu Hashim H

2015

Combined metformin-clomiphene in clomiphene-resistant polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials.